CPT code 54050 denotes the chemical destruction of a skin lesion on the penis, such as condyloma, papilloma, molluscum contagiosum, or a herpetic vesicle. This procedure, performed with local chemical agents to eradicate lesions and relieve pain, is a focused, often outpatient service relevant to urology, dermatology, and primary care practices. Nationally, accurate use of this code matters for clinical documentation, correct claim processing, and tracking office-based procedural care for sexually transmitted and other dermatologic conditions.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of service, plus guidance on what to expect in payer coverage approaches and common billing patterns. The publication covers benchmarks where available, coding best-practice considerations, and policy updates affecting outpatient procedural reimbursement. The content helps clinicians, coding professionals, and revenue cycle staff understand when CPT code 54050 applies, how it fits into procedural coding workflows, and what documentation elements are commonly required to support medical necessity. Data not available in the input is noted where applicable.